Inhaled technosphere regular insulin powder.
The lungs are an effective way to deliver insulin for patients with diabetes, but an initial inhaled insulin product was withdrawn from the market because of high cost and inconsistent dosing. This article describes a recently approved inhaled insulin that appears to control blood glucose as well as rapid-acting injectable insulin.
At the Presbyterian College School of Pharmacy in Clinton, S.C., Zachary L. Anderson is an assistant professor of pharmacy practice and Jennifer N. Clements is chair and an associate professor of pharmacy practice. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Zachary L
ZL
Anderson
Jennifer N
JN
Clements
D000280:Administration, Inhalation; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage*
D007004:Hypoglycemic Agents; D007328:Insulin